2019•OncogeneRequires access

Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology

Carlota Recio, Borja Guerra, Miguel Guerra-Rodríguez, Haidée Aranda-Tavío, Patricia Martin‐Rodríguez, Mercedes de Mirecki-Garrido, Yeray Brito‐Casillas, José Manuel García-Castellano, Ana Estévez‐Braun, Leandro Fernández‐Pérez

Open publisher page 43 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: STAT5, STAT protein, stat, Biology, JAK-STAT signaling pathway, Cancer research, STAT4, Haematopoiesis

Related papers

Back to paper searchBrowse research topicsOriginal source
Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology — Research Paper | ScholarLens